0
0

Discounted Drugs for Clinical Trials Act

12/29/2022, 11:48 PM

Congressional Summary of S 4026

Discounted Drugs for Clinical Trials Act

This bill allows researchers to obtain certain high-cost drugs and biologics at discounted prices from manufacturers. Researchers must apply to the Food and Drug Administration for approval; manufacturers must sell the approved quantity of drugs to researchers at the discounted price and are subject to civil actions from researchers for noncompliance.

Read the Full Bill

Formatted TextPDFFormatted XML

Current Status of Bill S 4026

Bill S 4026 is currently in the status of Bill Introduced since April 7, 2022. Bill S 4026 was introduced during Congress 117 and was introduced to the Senate on April 7, 2022.  Bill S 4026's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of April 7, 2022

Bipartisan Support of Bill S 4026

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
1
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 4026

Primary Policy Focus

Health

Alternate Title(s) of Bill S 4026

Discounted Drugs for Clinical Trials Act
Discounted Drugs for Clinical Trials Act
A bill to amend the Federal Food, Drug, and Cosmetic Act to grant eligible researchers access to eligible products at a discounted price for qualified research, and for other purposes.

Comments

Sponsors and Cosponsors of S 4026

Tina Smith
Tina Smith
MinnesotaDemocrat
Debbie Stabenow
Debbie Stabenow
MichiganDemocrat

Latest Bills

Protecting Families from AI Data Center Energy Costs Act
Bill HR 6529August 1, 2026
Prices on the Wall Act of 2026
Bill HR 9390August 1, 2026
Pipeline Safety Authorization Act of 2026
Bill HR 9338August 1, 2026
Ratepayer Protection Act
Bill HR 9340August 1, 2026
Tyler’s Law
Bill HR 2004August 1, 2026
Stop Pills That Kill Act
Bill HR 8005August 1, 2026
Load Forecasting Enhancement Act
Bill HR 9332August 1, 2026
EMRTAI Authorization Act of 2026
Bill HR 9616August 1, 2026
High-Capacity Grid Act
Bill HR 6633August 1, 2026
Combating Illicit Xylazine Act
Bill HR 1266August 1, 2026
Discounted Drugs for Clinical Trials Act
Bill S 4053December 29, 2022